Chronic pain and comorbid mood and substance use disorders: A biopsychosocial treatment approach

被引:23
|
作者
Cheatle M.D. [1 ]
Gallagher R.M. [1 ]
机构
[1] Behavioral Medicine Center, The Reading Hospital and Medical Center, Reading, PA 19612-6052
关键词
Chronic Pain; Neuropathic Pain; Chronic Pain Patient; Opioid Therapy; Opioid Addiction;
D O I
10.1007/s11920-006-0038-7
中图分类号
学科分类号
摘要
Chronic pain is a colossal heath care problem that is devastating to the individual afflicted with unremitting pain and frustrating to the beleaguered health care provider attempting to adequately manage this multifaceted disease. The biopsychosocial model of pain management is a promising approach that emphasizes evidence-based medication management in conjunction with cognitive-behavioral therapy and a graded exercise program. The patient with chronic pain and concomitant mood and/or substance use disorders is exceptionally challenging. Effective pharmacologic management of pain and comorbid mood disorders, including the thoughtful use of opioids, can have a dramatic effect in improving the quality of life in patients with chronic pain. The high prevalence of chronic pain in our society and the scarcity of experienced pain medicine physicians necessitate the development of a community-based systems approach to this complex patient population. Copyright © 2006 by Current Science Inc.
引用
收藏
页码:371 / 376
页数:5
相关论文
共 50 条
  • [1] Comorbid psychiatric disorders in chronic pain patients with psychoactive substance use disorders
    Fishbain, DA
    Cutler, RB
    Rosomoff, HL
    Rosomoff, RS
    [J]. PAIN CLINIC, 1998, 11 (02): : 79 - 87
  • [2] Pharmacotherapy of comorbid mood, anxiety, and substance use disorders
    Brady, KT
    Verduin, ML
    [J]. SUBSTANCE USE & MISUSE, 2005, 40 (13-14) : 2021 - 2041
  • [3] Exploring the use of Vibroacoustic treatment for managing chronic pain and comorbid mood disorders: A mixed methods study
    Campbell, Elsa A.
    Hynynen, Jouko
    Burger, Birgitta
    Ala-Ruona, Esa
    [J]. NORDIC JOURNAL OF MUSIC THERAPY, 2019, 28 (04) : 291 - 314
  • [4] Considering Ketamine for Treatment of Comorbid Pain, Depression, and Substance Use Disorders
    Ettensohn, Marc F.
    Markey, Sara M.
    Levine, Steven P.
    [J]. PSYCHIATRIC ANNALS, 2018, 48 (04) : 180 - 183
  • [5] A review of the neurobiological underpinning of comorbid substance use and mood disorders
    Gomez-Coronado, Nieves
    Sethi, Rickinder
    Bortolasci, Chiara Cristina
    Arancini, Lauren
    Berk, Michael
    Dodd, Seetal
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2018, 241 : 388 - 401
  • [6] Substance use disorders comorbid with mood and anxiety disorders in the Australian general population
    Prior, Katrina
    Mills, Katherine
    Ross, Joanne
    Teesson, Maree
    [J]. DRUG AND ALCOHOL REVIEW, 2017, 36 (03) : 317 - 324
  • [7] Mood Stabilizers in the Treatment of Substance Use Disorders
    Maremmani, Icro
    Pacini, Matteo
    Lamanna, Francesco
    Pani, Pier Paolo
    Perugi, Giulio
    Deltito, Joseph
    Salloum, Ihsan M.
    Akiskal, Hagop
    [J]. CNS SPECTRUMS, 2010, 15 (02) : 95 - 109
  • [8] Integrated treatment for mood and substance use disorders
    Albanese, MJ
    [J]. AMERICAN JOURNAL ON ADDICTIONS, 2006, 15 (02): : 199 - 199
  • [9] Integrated treatment for mood and substance use disorders
    Drake, RE
    [J]. PSYCHIATRIC SERVICES, 2004, 55 (05) : 595 - 595
  • [10] Integrated treatment for mood and substance use disorders
    Rounsaville, BJ
    [J]. ADDICTION, 2004, 99 (02) : 266 - 267